NAGE

Niagen Bioscience, Inc. Common Stock
NAGE

Overview Fund Activity

123 hedge funds and large institutions have $119M invested in Niagen Bioscience, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 34 increasing their positions, 26 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
123
Holders Change
+32
Holders Change %
+35.16%
% of All Funds
1.64%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
41
Increased
34
Reduced
26
Closed
7
Calls
$1.53M
Puts
$206K
Net Calls
+$1.33M
Net Calls Change
+$1.02M

Top Buyers

1
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$5.08M
2
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$2.61M
3
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$1.84M
4
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
+$1.76M
5
CSS
Cubist Systematic Strategies
Connecticut
+$1.65M

Top Sellers

1
TCM
Tieton Capital Management
Washington
-$1.95M
2
WG
Winton Group
United Kingdom
-$843K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$478K
4
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
-$338K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$216K
Name Holding Trade Value Shares
Change 		Shares
Change %
Acadian Asset Management
126
Acadian Asset Management
Massachusetts
– -$38K -10,430 Closed
Group One Trading
127
Group One Trading
Illinois
– -$26.6K -7,283 Closed
Allspring Global Investments
128
Allspring Global Investments
North Carolina
– -$6.37K -1,746 Closed
2 3 4 5
6